Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02743637
Title A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors (SDX-0101)
Acronym SDX-0101
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors SynDevRx, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Research Institute Scottsdale Arizona 85258 United States Details
Cedars Sinai Medical Center Los Angeles California 90048 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field